Xichun Hu

11PUBLICATIONS
59CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyPredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 11, 2026
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Mar 04, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Ting Li, Teng Zhou, Biyun Wang

|Dec 10, 2025
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Veronique Dieras, Giuseppe Curigliano, Miguel Martin

|Jul 31, 2025
Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Jian Zhang, Yanchun Meng, Biyun Wang

|Apr 17, 2025
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

Ting Zhao, Xiaowei Zhang, Xin Liu

Pageof 2

Frequent Collaborators

4 joint publications

Jian Zhang

2 joint publications

Joohyuk Sohn

2 joint publications

Eriko Tokunaga

1 joint publications

Guang-Hai Dai